US 8273709
Triazole-containing macrocyclic HCV serine protease inhibitors
granted A61KA61K38/00
Quick answer
US patent 8273709 (Triazole-containing macrocyclic HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00